Neoadjuvant Use of Sunitinib in Locally Advanced GIST with Intolerance to Imatinib

Publisher： Karger

E-ISSN： 1421-9794|58|1|30-33

ISSN： 0009-3157

Source： Chemotherapy, Vol.58, Iss.1, 2012-02, pp. : 30-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tailoring Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer: A Historical Prospective Study

By  

Chemotherapy, Vol. 58, Iss. 2, 2012-02 ,pp. : 95-101

Karger

Access to resources Recommend Favorite

The Addition of Target Therapy to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Review

By  

Chemotherapy, Vol. 62, Iss. 5, 2017-06 ,pp. : 314-322

Karger

Access to resources Recommend Favorite

Activity of Nilotinib (AMN-107) Alone in Advanced Gastrointestinal Stromal Tumors Progressing on Imatinib and Sunitinib

By  

Chemotherapy, Vol. 55, Iss. 2, 2009-02 ,pp. : 132-136

Karger

Access to resources Recommend Favorite

Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients

By Liu Jing   Chen Zhiyu   Chen Hanmei   Hou Yingyong   Lu Weiqi   He Junyi   Tong Hanxing   Zhou Yuhong   Cai Weimin  

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-03 ,pp. : 603-603

MDPI

Access to resources Recommend Favorite

A Phase I Trial of Sunitinib and Rapamycin in Patients with Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 59, Iss. 1, 2013-04 ,pp. : 8-13

Karger

Access to resources Recommend Favorite